212 related articles for article (PubMed ID: 19468266)
1. Molecular signatures in acute myeloid leukemia.
Mrózek K; Radmacher MD; Bloomfield CD; Marcucci G
Curr Opin Hematol; 2009 Mar; 16(2):64-9. PubMed ID: 19468266
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression in acute myeloid leukemia.
Marcucci G; Radmacher MD; Mrózek K; Bloomfield CD
Curr Hematol Malig Rep; 2009 Apr; 4(2):83-8. PubMed ID: 20425419
[TBL] [Abstract][Full Text] [Related]
3. The prognostic and functional role of microRNAs in acute myeloid leukemia.
Marcucci G; Mrózek K; Radmacher MD; Garzon R; Bloomfield CD
Blood; 2011 Jan; 117(4):1121-9. PubMed ID: 21045193
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia.
Jongen-Lavrencic M; Sun SM; Dijkstra MK; Valk PJ; Löwenberg B
Blood; 2008 May; 111(10):5078-85. PubMed ID: 18337557
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Langer C; Marcucci G; Holland KB; Radmacher MD; Maharry K; Paschka P; Whitman SP; Mrózek K; Baldus CD; Vij R; Powell BL; Carroll AJ; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2009 Jul; 27(19):3198-204. PubMed ID: 19451432
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
Marcucci G; Maharry K; Radmacher MD; Mrózek K; Vukosavljevic T; Paschka P; Whitman SP; Langer C; Baldus CD; Liu CG; Ruppert AS; Powell BL; Carroll AJ; Caligiuri MA; Kolitz JE; Larson RA; Bloomfield CD
J Clin Oncol; 2008 Nov; 26(31):5078-87. PubMed ID: 18809607
[TBL] [Abstract][Full Text] [Related]
7. Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia.
Mrózek K; Marcucci G; Paschka P; Bloomfield CD
Curr Opin Oncol; 2008 Nov; 20(6):711-8. PubMed ID: 18841055
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
Marcucci G; Haferlach T; Döhner H
J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
[TBL] [Abstract][Full Text] [Related]
10. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
Shi JL; Fu L; Wang WD
Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
[TBL] [Abstract][Full Text] [Related]
11. Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics.
Marcucci G; Mrózek K; Bloomfield CD
Curr Opin Hematol; 2005 Jan; 12(1):68-75. PubMed ID: 15604894
[TBL] [Abstract][Full Text] [Related]
12. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
Becker H; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Margeson D; Whitman SP; Wu YZ; Schwind S; Paschka P; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2010 Feb; 28(4):596-604. PubMed ID: 20026798
[TBL] [Abstract][Full Text] [Related]
13. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
[TBL] [Abstract][Full Text] [Related]
14. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
Baldus CD; Bullinger L
Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
[TBL] [Abstract][Full Text] [Related]
15. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias.
Marcucci G; Mrózek K; Radmacher MD; Bloomfield CD; Croce CM
Best Pract Res Clin Haematol; 2009 Jun; 22(2):239-48. PubMed ID: 19698931
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.
Mi S; Lu J; Sun M; Li Z; Zhang H; Neilly MB; Wang Y; Qian Z; Jin J; Zhang Y; Bohlander SK; Le Beau MM; Larson RA; Golub TR; Rowley JD; Chen J
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19971-6. PubMed ID: 18056805
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of cytogenetically normal acute myeloid leukemia identifies microRNAs that target genes involved in monocytic differentiation.
Lutherborrow M; Bryant A; Jayaswal V; Agapiou D; Palma C; Yang YH; Ma DD
Am J Hematol; 2011 Jan; 86(1):2-11. PubMed ID: 20981674
[TBL] [Abstract][Full Text] [Related]
19. Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.
Obulkasim A; Katsman-Kuipers JE; Verboon L; Sanders M; Touw I; Jongen-Lavrencic M; Pieters R; Klusmann JH; Michel Zwaan C; van den Heuvel-Eibrink MM; Fornerod M
Oncotarget; 2017 May; 8(20):33078-33085. PubMed ID: 28380436
[TBL] [Abstract][Full Text] [Related]
20. Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insights.
Bullinger L; Fröhling S
Semin Oncol; 2012 Feb; 39(1):37-46. PubMed ID: 22289490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]